Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Henning Flechtner

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
BMC Cancer|October 8, 2021
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trialsEva M Gamper, Jammbe Z Musoro, Corneel Coens, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanomaJammbe Z Musoro, Andrew Bottomley, Corneel Coens, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2022
Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65-72]Michael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
Praxis Der Kinderpsychologie Und Kinderpsychiatrie|April 20, 2013
["I do not worry about ...!" How the Berkeley Puppet Interview may reveal self-report of psychological symptoms of 4 to 8 years old children exposed to parental cancer]Gabriele Koch, Stefanie Dieball, Carina Falk, et al.
Cancer|June 25, 2014
Children of cancer patients: prevalence and predictors of emotional and behavioral problemsBirgit Möller, Claus Barkmann, Thomas Krattenmacher, et al.
JNCI Cancer Spectrum|April 25, 2020
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast CancerJammbe Z Musoro, Corneel Coens, Frederic Fiteni, et al.
Gynecologic Oncology|September 25, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancerJammbe Z Musoro, Corneel Coens, Elfriede Greimel, et al.
BMJ Open|January 13, 2018
Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocolZebedee Jammbe Musoro, Jean-Francois Hamel, Divine Ewane Ediebah, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
The Lancet. Oncology|September 11, 2016
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study GroupStefanie Kreissl, Horst Mueller, Helen Goergen, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
BMC Cancer|October 8, 2021
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trialsEva M Gamper, Jammbe Z Musoro, Corneel Coens, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanomaJammbe Z Musoro, Andrew Bottomley, Corneel Coens, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2022
Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65-72]Michael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
Praxis Der Kinderpsychologie Und Kinderpsychiatrie|April 20, 2013
["I do not worry about ...!" How the Berkeley Puppet Interview may reveal self-report of psychological symptoms of 4 to 8 years old children exposed to parental cancer]Gabriele Koch, Stefanie Dieball, Carina Falk, et al.
Cancer|June 25, 2014
Children of cancer patients: prevalence and predictors of emotional and behavioral problemsBirgit Möller, Claus Barkmann, Thomas Krattenmacher, et al.
JNCI Cancer Spectrum|April 25, 2020
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast CancerJammbe Z Musoro, Corneel Coens, Frederic Fiteni, et al.
Gynecologic Oncology|September 25, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancerJammbe Z Musoro, Corneel Coens, Elfriede Greimel, et al.
BMJ Open|January 13, 2018
Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocolZebedee Jammbe Musoro, Jean-Francois Hamel, Divine Ewane Ediebah, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
The Lancet. Oncology|September 11, 2016
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study GroupStefanie Kreissl, Horst Mueller, Helen Goergen, et al.
Pageof 7